Skip to main content

Cardiovascular risk associated with hypertension; interactions with other risk indicators

  • Chapter
Practical Management of Hypertension

Abstract

A risk indicator is generally defined as a factor associated with the occurrence of a particular disease. The association between a risk factor and a disease is often, although not necessarily, causal. Risk is usually expressed as the relative increase or decrease in the probability of having or acquiring the disease when the risk indicator moves from one level to another. Risk estimates include random biological variation in the strength of the association between a particular risk factor and an illness. Thus, when a patient is a carrier of a certain risk factor, this does not automatically imply that he or she will become diseased.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected references

  • Amery A, Fagard R, Staessen J (1987): Recent data on changes in lipid metabolism induced by hypotensive drugs. Cuir Opinion Cardiol 2: 769–774.

    Article  Google Scholar 

  • Carr SJ, Thomas TH, Laker MF, Wilkinson R (1990): Elevated sodium—lithium countertransport: a familial marker of hyperlipidaemia and hypertension. J Hypertension 8: 139–146.

    Article  CAS  Google Scholar 

  • Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH (1990): Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1: 827–838.

    Article  Google Scholar 

  • Fielding JE (1985): Smoking: health effects and control. NEngl JMed 313: 491–498.

    Article  CAS  Google Scholar 

  • Handbook of Hypertension (Series Editors WH Birkenhäger, JL Reid). Volume 12. Hypertension in the Elderly (Eds. A Amery, J Staessen). Elsevier, Amsterdam, 1989.

    Google Scholar 

  • Handbook of Hypertension (Series Editors WH Birkenhäger, JL Reid). Volume 6.Epidemiology of Hypertension. (Ed. CJ Bulpitt). Elsevier, Amsterdam, 1985.

    Google Scholar 

  • Kannel WB (1974): Role of blood pressure in cardiovascular epidemiology. Prog Cardiovasc Dis 17: 5–24.

    Article  PubMed  CAS  Google Scholar 

  • Kannel WB (1976): Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 37: 269–282.

    Article  PubMed  CAS  Google Scholar 

  • Kannel WB (1990): Contribution of the Framingham Study to preventive cardiology. JAm Coll Cardiol 15: 206–211.

    Article  CAS  Google Scholar 

  • Kaplan NM (1989): The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyeridaemia, and hypertension. Arch Intern Med 149: 1514–1520.

    Article  PubMed  CAS  Google Scholar 

  • Klatsky AL, Friedman GD, Siegelaub AB (1981): Alcohol use and cardiovascular disease: the Kaiser-Permanente experience. Circulation 64 (Suppl III): III32–III41.

    CAS  Google Scholar 

  • Levy D (1988): Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs Suppl 5: 1–5.

    Article  Google Scholar 

  • Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990): Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561–1566.

    Article  PubMed  CAS  Google Scholar 

  • MacMahon SW, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990): Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765–774.

    Article  PubMed  CAS  Google Scholar 

  • Stadel BV (1981): Oral contraceptives and cardiovascular disease. NEngl JMed 305: 672–677.

    Article  CAS  Google Scholar 

  • Staessen J, Fagard R, Van Hoof R, Amery A (1988): Mortality in various intervention trials in elderly hypertensive patients. Eur Heart J 9: 215–222.

    PubMed  CAS  Google Scholar 

  • Staessen J, Fagard R, Amery A (1988): The relationship between body weight and blood pressure. JHuman Hypertension 2: 207–217.

    CAS  Google Scholar 

  • Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery P (1989): The influence of menopause on blood pressure. J Human Hypertension 3: 427–433.

    CAS  Google Scholar 

  • Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH (1988): Prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 319: 1313–1317.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Staessen, J., Fagard, R., Amery, A. (1990). Cardiovascular risk associated with hypertension; interactions with other risk indicators. In: Birkenhäger, W.H. (eds) Practical Management of Hypertension. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3724-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3724-9_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5655-7

  • Online ISBN: 978-94-011-3724-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics